BR0002265A - Inibidores da metaloprotease, um processo para seu preparo e composições farmacêuticas contendo os mesmos - Google Patents

Inibidores da metaloprotease, um processo para seu preparo e composições farmacêuticas contendo os mesmos

Info

Publication number
BR0002265A
BR0002265A BR0002265-9A BR0002265A BR0002265A BR 0002265 A BR0002265 A BR 0002265A BR 0002265 A BR0002265 A BR 0002265A BR 0002265 A BR0002265 A BR 0002265A
Authority
BR
Brazil
Prior art keywords
group
preparation
pharmaceutical compositions
compositions containing
same
Prior art date
Application number
BR0002265-9A
Other languages
English (en)
Inventor
Guillaume De Nanteuil
Alain Benoist
Jacqueline Bonnet
Massimo Sabatini
Ghanem Atassi
Alain Pierre
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of BR0002265A publication Critical patent/BR0002265A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)

Abstract

Patente de Invenção: <B>''INIBIDORES DA METALOPROTEASE, UM PROCESSO PARA SEU PREPARO E COMPOSIçõES FARMACêUTICAS CONTENDO OS MESMOS''<D>. Compostos da fórmula (I): em que: R~ 1~ representa um átomo de hidrogênio ou halogênio ou um grupo alquila ou alcóxi, R~ 2~ representa um grupo hidróxi, alcóxi ou -NHOH, Ar~ 1~ representa um grupo fenileno ou bifenileno, X representa um átomo de oxigênio ou enxofre, um grupo NR, um grupo -C<154>C- ou uma ligação, R representa um átomo de hidrogênio ou um grupo alquila, n é um número inteiro de 0 a 6 inclusive, Ar~ 2~ representa qualquer um dos grupos definidos na descrição, seus isómeros e sais de adição dos mesmos com um ácido ou base farmaceuticamente aceitável.
BR0002265-9A 1999-07-01 2000-07-03 Inibidores da metaloprotease, um processo para seu preparo e composições farmacêuticas contendo os mesmos BR0002265A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9908448A FR2795730B1 (fr) 1999-07-01 1999-07-01 Nouveaux inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
BR0002265A true BR0002265A (pt) 2001-03-13

Family

ID=9547562

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0002265-9A BR0002265A (pt) 1999-07-01 2000-07-03 Inibidores da metaloprotease, um processo para seu preparo e composições farmacêuticas contendo os mesmos

Country Status (22)

Country Link
US (1) US6339092B1 (pt)
EP (1) EP1065209B1 (pt)
JP (1) JP3330583B2 (pt)
KR (1) KR100472521B1 (pt)
CN (1) CN1147492C (pt)
AT (1) ATE239021T1 (pt)
AU (1) AU770168B2 (pt)
BR (1) BR0002265A (pt)
CA (1) CA2313302C (pt)
DE (1) DE60002395T2 (pt)
DK (1) DK1065209T3 (pt)
EA (1) EA002527B1 (pt)
ES (1) ES2198262T3 (pt)
FR (1) FR2795730B1 (pt)
HK (1) HK1034968A1 (pt)
HU (1) HUP0002554A3 (pt)
NO (1) NO20003431L (pt)
NZ (1) NZ505522A (pt)
PL (1) PL341134A1 (pt)
PT (1) PT1065209E (pt)
SI (1) SI1065209T1 (pt)
ZA (1) ZA200003310B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6770647B2 (en) * 2001-08-17 2004-08-03 Bristol-Myers Squibb Pharma Company Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)
DE102005002500A1 (de) * 2005-01-19 2006-07-27 Sanofi-Aventis Deutschland Gmbh Tetrahydrofuranderivate als Inhibitoren von Matrix-Metalloproteinasen
WO2009086138A1 (en) * 2007-12-21 2009-07-09 Wyeth Benzimidazole compounds
KR100962022B1 (ko) 2010-01-12 2010-06-08 (주) 유니크코리아엔아이 정전용량형 압력센서 및 그 제조방법
CN105189515B (zh) * 2013-03-14 2018-07-03 葛兰素史克知识产权第二有限公司 作为溴结构域抑制剂的呋喃并吡啶类

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2748026B1 (fr) * 1996-04-26 1998-06-05 Adir Nouveaux inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE19719817A1 (de) * 1997-05-13 1998-11-19 Hoechst Ag Substituierte 6- und 7-Aminotetrahydroisochinolincarbonsäuren
CA2297988A1 (en) * 1997-08-04 1999-02-11 Amgen Inc. Hydroxamic acid substituted fused heterocyclic metalloproteinase inhibitors

Also Published As

Publication number Publication date
SI1065209T1 (en) 2003-08-31
US6339092B1 (en) 2002-01-15
CA2313302A1 (fr) 2001-01-01
CA2313302C (fr) 2004-06-15
EA200000598A1 (ru) 2001-02-26
AU770168B2 (en) 2004-02-12
NZ505522A (en) 2001-12-21
DK1065209T3 (da) 2003-08-25
EP1065209A1 (fr) 2001-01-03
NO20003431L (no) 2001-01-02
HK1034968A1 (en) 2001-11-09
PL341134A1 (en) 2001-01-02
CN1147492C (zh) 2004-04-28
DE60002395D1 (de) 2003-06-05
ES2198262T3 (es) 2004-02-01
JP2001039983A (ja) 2001-02-13
FR2795730A1 (fr) 2001-01-05
AU4378400A (en) 2001-01-04
DE60002395T2 (de) 2004-04-08
EP1065209B1 (fr) 2003-05-02
NO20003431D0 (no) 2000-06-30
PT1065209E (pt) 2003-08-29
FR2795730B1 (fr) 2001-08-31
ZA200003310B (en) 2001-01-25
JP3330583B2 (ja) 2002-09-30
CN1290703A (zh) 2001-04-11
HU0002554D0 (en) 2000-08-28
EA002527B1 (ru) 2002-06-27
HUP0002554A2 (hu) 2002-04-29
ATE239021T1 (de) 2003-05-15
KR20010039689A (ko) 2001-05-15
HUP0002554A3 (en) 2002-12-28
KR100472521B1 (ko) 2005-03-08

Similar Documents

Publication Publication Date Title
BR9913592A (pt) Compostos, processo de preparação dos compostos, e, composições farmacêuticas
BR0210297A (pt) Derivados de n-arilfenilacetamida e composição farmacêutcia contendo os mesmos
BR9911771A (pt) Compostos cìclicos substituìdos, um processo para sua preparação e composições farmacêuticas que contêm os mesmos
PT1058683E (pt) Inibidores da farnesil-transferase com uma estrutura de piperidina e seu processo de preparacao
BRPI0016395B8 (pt) derivados de adamantano
BR0108893A (pt) Composição farmacêutica, composto e processo de preparação de compostos
BR0316386A (pt) Benzoxazin-3-onas e seus derivados como inibidores de p13k
BRPI0015203B8 (pt) derivado de quinazolina, composição farmacêutica, e, uso de um composto
BR9908325A (pt) 6 9-dissubstituìdo 2-[trans-4(4-aminociclohexil)amino]purinas
BR0208489A (pt) Derivados de n-(arilsulfonil) beta-aminoácidos, comportando um grupo aminoetilado substituìdo, o respectivo processo de preparação e as composições farmacêuticas que os contêm
BR9911274A (pt) Derivados da artemisinina, seus processos de preparação e as composições farmacêuticas que os contêm
BR9802804A (pt) Compostos benzimidazol, benzoxazol e benzotiazol, processo para sua preparação e composições farmacéuticas contendo os mesmos.
BR9813124A (pt) Compostos indol 2,3-substituìdos como inibidores cox-2
BR0003848A (pt) Compostos de piridina, processo para sua preparação e composições farmacêuticas que os contêm
BR0104471A (pt) Compostos de ciclobutenodiona, um processo para a preparação dos mesmos e composições farmacêuticas que contêm os mesmos
BR0100234A (pt) Compostos de piperidina-4-sulfonamida, processo para a sua preparação e composições farmacêuticas contendo os mesmos
BR0308765A (pt) Compostos (4,2-dissubstituìdo-tiazol-5-il)amina como inibidores de pde7
BR0011282A (pt) Derivados da purina, seu processo de preparo e composiçoes farmacêuticas que as contêm
BR0106248A (pt) Inibidores de metaloprotease, processo para a sua preparação e composições farmacêuticas contendo os mesmos
BR0002265A (pt) Inibidores da metaloprotease, um processo para seu preparo e composições farmacêuticas contendo os mesmos
HRP20060023A2 (en) Use of bicyclo[2.2.1]heptane derivatives for the preparation of neuroprotective pharmaceutical compositions
BR0004823A (pt) Compostos policìclicos de azaindol, processo para a preparação dos mesmos e composições farmacêuticas contendo os mesmos
UY24697A1 (es) Metodos para producir inhibidores de vih-proteasa y productos intermedios para producir inhibidores de vih-proteasa
BR0308807A (pt) Compostos tiazol-2-il-imina como inibidores de pde-7
BR9903867A (pt) Compsto de indan-1-ol, processo para seu preparo e compostos farmacêuticos contento os mesmo

Legal Events

Date Code Title Description
PC Transfer

Free format text: LES LABORATOIRES SERVIER (FR)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7O, 8O E 9O ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 NA RPI2003 DE 26/05/2009.